drugset / Trial / NCT06932393

Exosomes for Hairloss Treatment

NCT06932393

Phase 0 Terminated 16 enrolled Guangzhou Bio-gene Technology Co., Ltd
RandomizedCrossoverDouble-blindTreatment

Summary

Many people suffer from alopecia, which is caused by hereditary factors, emotional stress, and psychiatric disorders. There are devastating physical and psychological consequences as a result. Exosomes are isolated from donated human mesenchymal stem cells and purified using specific processing. This study is a randomized, double-blind, dose-escalation clinical trial designed to evaluate the efficacy and safety of exosomes therapy for alopecia.

Timeline

Start
2025-04-30
Primary completion
2026-04-17
Completion
2026-04-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Exosomes Other / unclassified 5e+08 unknown Other
Subject Exosomes Other / unclassified 5e+09 unknown Other

Indications